The synergistic immunoregulatory effects of culture-expanded mesenchymal stromal cells and CD4(+)25(+)Foxp3+ regulatory T cells on skin allograft rejection.

Mesenchymal stromal cells (MSCs) are seen as an ideal source of cells to induce graft acceptance; however, some reports have shown that MSCs can be immunogenic rather than immunosuppressive. We speculate that the immunomodulatory effects of regulatory T cells (Tregs) can aid the maintenance of immun...

Full description

Bibliographic Details
Main Authors: Jung Ho Lee, Eun-Joo Jeon, Nayoun Kim, Young-Sun Nam, Keon-Il Im, Jung-Yeon Lim, Eun-Jung Kim, Mi-La Cho, Ki Taik Han, Seok-Goo Cho
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3733648?pdf=render
_version_ 1819265432301862912
author Jung Ho Lee
Eun-Joo Jeon
Nayoun Kim
Young-Sun Nam
Keon-Il Im
Jung-Yeon Lim
Eun-Jung Kim
Mi-La Cho
Ki Taik Han
Seok-Goo Cho
author_facet Jung Ho Lee
Eun-Joo Jeon
Nayoun Kim
Young-Sun Nam
Keon-Il Im
Jung-Yeon Lim
Eun-Jung Kim
Mi-La Cho
Ki Taik Han
Seok-Goo Cho
author_sort Jung Ho Lee
collection DOAJ
description Mesenchymal stromal cells (MSCs) are seen as an ideal source of cells to induce graft acceptance; however, some reports have shown that MSCs can be immunogenic rather than immunosuppressive. We speculate that the immunomodulatory effects of regulatory T cells (Tregs) can aid the maintenance of immunoregulatory functions of MSCs, and that a combinatorial approach to cell therapy can have synergistic immunomodulatory effects on allograft rejection. After preconditioning with Fludarabine, followed by total body irradiation and anti-asialo-GM-1(ASGM-1), tail skin grafts from C57BL/6 (H-2k(b)) mice were grafted onto the lateral thoracic wall of BALB/c (H-2k(d)) mice. Group A mice (control group, n = 9) did not receive any further treatment after preconditioning, whereas groups B and C (n = 9) received cell therapy with MSCs or Tregs, respectively, on days -1, +6 and +13 relative to the skin transplantation. Group D (n = 10) received cell therapy with MSCs and Tregs on days -1, +6 and +13. Cell suspensions were obtained from the spleens of five randomly chosen mice from each group on day +7, and the immunomodulatory effects of the cell therapy were evaluated by flow cytometry and real-time PCR. Our results show that allograft survival was significantly longer in group D compared to the control group (group A). Flow cytometric analysis and real-time PCR for splenocytes revealed that the Th2 subpopulation in group D increased significantly compared to the group B. Also, the expression of Foxp3 and STAT 5 increased significantly in group D compared to the conventional cell therapy groups (B and C). Taken together, these data suggest that a combined cell therapy approach with MSCs and Tregs has a synergistic effect on immunoregulatory function in vivo, and might provide a novel strategy for improving survival in allograft transplantation.
first_indexed 2024-12-23T20:45:17Z
format Article
id doaj.art-181121d264284164b23f3122058a11e5
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-23T20:45:17Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-181121d264284164b23f3122058a11e52022-12-21T17:31:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0188e7096810.1371/journal.pone.0070968The synergistic immunoregulatory effects of culture-expanded mesenchymal stromal cells and CD4(+)25(+)Foxp3+ regulatory T cells on skin allograft rejection.Jung Ho LeeEun-Joo JeonNayoun KimYoung-Sun NamKeon-Il ImJung-Yeon LimEun-Jung KimMi-La ChoKi Taik HanSeok-Goo ChoMesenchymal stromal cells (MSCs) are seen as an ideal source of cells to induce graft acceptance; however, some reports have shown that MSCs can be immunogenic rather than immunosuppressive. We speculate that the immunomodulatory effects of regulatory T cells (Tregs) can aid the maintenance of immunoregulatory functions of MSCs, and that a combinatorial approach to cell therapy can have synergistic immunomodulatory effects on allograft rejection. After preconditioning with Fludarabine, followed by total body irradiation and anti-asialo-GM-1(ASGM-1), tail skin grafts from C57BL/6 (H-2k(b)) mice were grafted onto the lateral thoracic wall of BALB/c (H-2k(d)) mice. Group A mice (control group, n = 9) did not receive any further treatment after preconditioning, whereas groups B and C (n = 9) received cell therapy with MSCs or Tregs, respectively, on days -1, +6 and +13 relative to the skin transplantation. Group D (n = 10) received cell therapy with MSCs and Tregs on days -1, +6 and +13. Cell suspensions were obtained from the spleens of five randomly chosen mice from each group on day +7, and the immunomodulatory effects of the cell therapy were evaluated by flow cytometry and real-time PCR. Our results show that allograft survival was significantly longer in group D compared to the control group (group A). Flow cytometric analysis and real-time PCR for splenocytes revealed that the Th2 subpopulation in group D increased significantly compared to the group B. Also, the expression of Foxp3 and STAT 5 increased significantly in group D compared to the conventional cell therapy groups (B and C). Taken together, these data suggest that a combined cell therapy approach with MSCs and Tregs has a synergistic effect on immunoregulatory function in vivo, and might provide a novel strategy for improving survival in allograft transplantation.http://europepmc.org/articles/PMC3733648?pdf=render
spellingShingle Jung Ho Lee
Eun-Joo Jeon
Nayoun Kim
Young-Sun Nam
Keon-Il Im
Jung-Yeon Lim
Eun-Jung Kim
Mi-La Cho
Ki Taik Han
Seok-Goo Cho
The synergistic immunoregulatory effects of culture-expanded mesenchymal stromal cells and CD4(+)25(+)Foxp3+ regulatory T cells on skin allograft rejection.
PLoS ONE
title The synergistic immunoregulatory effects of culture-expanded mesenchymal stromal cells and CD4(+)25(+)Foxp3+ regulatory T cells on skin allograft rejection.
title_full The synergistic immunoregulatory effects of culture-expanded mesenchymal stromal cells and CD4(+)25(+)Foxp3+ regulatory T cells on skin allograft rejection.
title_fullStr The synergistic immunoregulatory effects of culture-expanded mesenchymal stromal cells and CD4(+)25(+)Foxp3+ regulatory T cells on skin allograft rejection.
title_full_unstemmed The synergistic immunoregulatory effects of culture-expanded mesenchymal stromal cells and CD4(+)25(+)Foxp3+ regulatory T cells on skin allograft rejection.
title_short The synergistic immunoregulatory effects of culture-expanded mesenchymal stromal cells and CD4(+)25(+)Foxp3+ regulatory T cells on skin allograft rejection.
title_sort synergistic immunoregulatory effects of culture expanded mesenchymal stromal cells and cd4 25 foxp3 regulatory t cells on skin allograft rejection
url http://europepmc.org/articles/PMC3733648?pdf=render
work_keys_str_mv AT jungholee thesynergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT eunjoojeon thesynergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT nayounkim thesynergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT youngsunnam thesynergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT keonilim thesynergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT jungyeonlim thesynergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT eunjungkim thesynergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT milacho thesynergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT kitaikhan thesynergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT seokgoocho thesynergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT jungholee synergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT eunjoojeon synergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT nayounkim synergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT youngsunnam synergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT keonilim synergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT jungyeonlim synergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT eunjungkim synergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT milacho synergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT kitaikhan synergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection
AT seokgoocho synergisticimmunoregulatoryeffectsofcultureexpandedmesenchymalstromalcellsandcd425foxp3regulatorytcellsonskinallograftrejection